Monte Rosa Therapeutics (GLUE) Shares Outstanding (Diluted) (2021 - 2026)
Powered by 
Analysis
Monte Rosa Therapeutics (GLUE) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | 255.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 106.00 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 66.03 Mn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 115.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 138.28 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | 556.90 Mn |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Monte Rosa Therapeutics | 1.42 Bn | 782.73 Mn | - | 101.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 101.48 Mn |
| Mar 31, 2026 | 99.88 Mn |
| Dec 31, 2025 | 83.07 Mn |
| Sep 30, 2025 | 82.40 Mn |
| Jun 30, 2025 | 82.19 Mn |
| Mar 31, 2025 | 82.96 Mn |
| Dec 31, 2024 | 73.91 Mn |
| Sep 30, 2024 | 82.01 Mn |
| Jun 30, 2024 | 71.23 Mn |
| Mar 31, 2024 | 60.16 Mn |
| Dec 31, 2023 | 51.40 Mn |
| Sep 30, 2023 | 49.81 Mn |
| Jun 30, 2023 | 49.43 Mn |
| Mar 31, 2023 | 49.35 Mn |
| Dec 31, 2022 | 47.23 Mn |
| Sep 30, 2022 | 46.73 Mn |
| Jun 30, 2022 | 46.67 Mn |
| Mar 31, 2022 | 46.60 Mn |
| Dec 31, 2021 | 25.00 Mn |
| Sep 30, 2021 | 45.99 Mn |